Nucleai

About:

Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes.

Website: https://nucleai.ai/

Twitter/X: NucleaiMd

Top Investors: M Ventures, Grove Ventures, Section 32, Sanofi Ventures, Debiopharm Innovation Fund

Description:

Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies, licensing its research platform for internal use, and collaborating in biomarkers discovery projects.